UNSPSC 51191572: Amiloride hydrochloride

This classification denotes a potassium-sparing diuretic and intercalating agent with the molecular formula C6H8ClN7O.ClH.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FZJ37245UC, chemically known as pyrazinecarboxamide, n-amidino-3,5-diamino-6-chloro-, monohydrochloride but more generally known as amiloride hydrochloride, which bears US NIH Compound Identifier 16230. European Medicines Agency schedules Amiloride hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00445MIG.

UNSPSC 51191572 Amiloride hydrochloride is a Commodity code that shows limited recent state and local procurement activity aligned with its nominal pharmaceutical scope. The three recent opportunities tagged under this code do not reflect pharmaceutical procurement: instead, they span wastewater infrastructure valves and repair services (Broward County, Florida), parenteral nutrition and intravenous solutions for a correctional healthcare system (Washington State Department of Corrections), and sodium bisulfite chemical supply for municipal water treatment (City of Meriden, Connecticut). The code appears to be tagged inconsistently or applied to broader pharmaceutical and chemical supply categories rather than the specific diuretic agent named in the code itself. State and local issuing bodies posting under this code include county purchasing offices, state health and corrections agencies, and municipal utilities, though the recent sample is too small to characterize repeat-buyer patterns.

Geographic activity is dispersed across Florida, Washington, and Connecticut based on recent postings, with no clear concentration. Representative recent opportunities include the Washington State Department of Corrections RFQ for parenteral products, services, and equipment due October 7, 2026, soliciting multiple contractors to supply parenteral nutrition, intravenous solutions, and controlled substances to eight correctional facilities across three regions with delivery windows as tight as 8 hours, and the City of Meriden IFB for sodium bisulfite chemical supply posted August 14, 2026. The code does not show robust recent activity in pharmaceutical procurement aligned with amiloride hydrochloride specifically, suggesting either sparse genuine demand for this commodity under this code or systematic misclassification in state and local tagging.